ImmunoCellular Therapeutics
| Region | Nordamerika |
| ISIN | US4525362046 |
| Sektor | Biotechnologie |
| Website | http://www.imuc.com/ |
ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.
| Titel | Datum |
|---|---|
| MPA Singapore and MISC to support digital transformation in maritime industry | vor ungefähr 5 Monaten |
| The Maritime and Port Authority of Singapore and MISC forge partnership | vor ungefähr 5 Monaten |
| MPA and MISC Partner Up for Maritime Ops Digitalization | vor ungefähr 5 Monaten |
| Malaysia's Gentari, MISC forge strategic partnership to advance ammonia shipping and floating solutions | vor ungefähr 5 Monaten |
| MISC and Gentari forge strategic partnership to advance ammonia shipping and floating solutions | vor ungefähr 5 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Idea Fabrik (3 Artikel) | |
| Iconic Minerals (2 Artikel) | |
| Incyte (1 Artikel) | |
| India Globalization Capital (2 Artikel) | |
| Alle anzeigen | |